New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export JNJ’s income statement to Excel — free account
Johnson & Johnson
JNJHealthcare Drug Manufacturers General
Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.
- Revenue
- +5.86%
- EPS
- −95.8%
- Free cash flow
- −21.4%
- Total debt
- −9.16%
Quarter to September 2026, against a year earlier
271.02
3.92
+1.47%
Follow JNJ
Alert me
Johnson & Johnson (JNJ) SEC filings, changes and red flags
Red flags
-
Officer departure
Johnson & Johnson reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 27, 2026 |
P1I2: 25 added · 29 removed · 35 modified P2I1A: no comparison — the Item was not found |
||
| 8-K | Oct 13, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 4, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | Officer departure | |
| 8-K | Jul 29, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jul 27, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 28, 2026 |
P1I2: 48 added · 13 removed · 34 modified P2I1A: no comparison — the Item was not found |
||
| 8-K | Jul 15, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 23, 2026 | 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 29, 2026 |
P1I2: 13 added · 64 removed · 42 modified P2I1A: no comparison — the Item was not found |
||
| 8-K | Apr 14, 2026 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 28, 2025 |
1: 2 added · 4 removed · 21 modified 1A: 5 added · 10 modified 7: 27 added · 31 removed · 57 modified |
||
| 8-K | Jan 21, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 28, 2025 |
P1I2: 26 added · 20 removed · 52 modified P2I1A: no comparison — the Item was not found |
||
| 8-K | Oct 14, 2025 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Sep 8, 2025 | 5.02 Departure or appointment of directors or officers | ||
| 10-Q | Jun 29, 2025 |
P1I2: 51 added · 12 removed · 40 modified P2I1A: no comparison — the Item was not found |
||
| 8-K | Jul 16, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 30, 2025 | |||
| 8-K | Apr 15, 2025 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 29, 2024 |
1: no comparison — no earlier filing on file 1A: no comparison — no earlier filing on file 7: no comparison — no earlier filing on file |
||
| 8-K | Jan 22, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 29, 2024 | |||
| 8-K | Oct 15, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 17, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 1, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 16, 2024 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 23, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits |